1. Burd C, Cullen PJ. Retromer: A Master Conductor of Endosome Sorting. Cold Spring Harb Perspect Biol. 2014; doi:10.1101/cshperspect.a016774
2. Bonifacino JS, Rojas R. Retrograde transport from endosomes to the trans-Golgi network. Nat Rev Mol Cell Biol. 2006; doi: 10.1038/nrm1985
3. Cullen PJ, Korswagen HC. Sorting nexins provide diversity for retromer-dependent trafficking events. Nat Cell Biol. 2011; doi: 10.1038/ncb2374
4. Seaman MNJ, Gautreau A, Billadeau DD. Retromer-mediated endosomal protein sorting: all WASHed up! Trends Cell Biol. 2013; doi: 10.1016/j.tcb.2013.04.010
5. Struhal W, Presslauer S, Spielberger S, Zimprich A, Auff E, Bruecke T, et al. VPS35 Parkinson’s disease phenotype resembles the sporadic disease. J Neural Transm. 2014; doi: 10.1007/s00702-014-1179-1
6. Vilariño-Güell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, Lincoln SJ, et al. VPS35 mutations in Parkinson disease. Am J Hum Genet. 2011; doi: 10.1016/j.ajhg.2011.06.001
7. Zimprich A, Benet-Pagès A, Struhal W, Graf E, Eck SH, Offman MN, et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet. 2011; doi: 10.1016/j.ajhg.2011.06.008
8. Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, et al. Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease. Brain. 2013; doi: 10.1093/brain/awt192
9. Beitz JM. Parkinson’s disease: a review. Front Biosci. 2014; doi: 10.2741/s415
10. Goldman JG, Postuma R. Premotor and nonmotor features of Parkinson’s disease. Curr Opin Neurol. 2014; doi: 10.1097/WCO.0000000000000112
11. Foffani G, Obeso JA. A Cortical Pathogenic Theory of Parkinson’s Disease. Neuron. 2018; doi: 10.1016/j.neuron.2018.07.028
12. Chen X, Kordich JK, Williams ET, Levine N, Cole-Strauss A, Marshall L, et al. Parkinson’s disease-linked D620N VPS35 knock-in mice manifest tau neuropathology and dopaminergic neurodegeneration. Proc Natl Acad Sci U S A. 2019; doi: 10.1073/pnas.1814909116
13. Niu M, Zhao F, Bondelid K, Siedlak SL, Torres S, Fujioka H, et al. VPS35 D620N knockin mice recapitulate cardinal features of Parkinson’s disease. Aging Cell. 2021; doi: 10.1111/acel.13347
14. Choy RW-Y, Park M, Temkin P, Herring BE, Marley A, Nicoll R a, et al. Retromer mediates a discrete route of local membrane delivery to dendrites. Neuron. 2014; doi: 10.1016/j.neuron.2014.02.018
15. Munsie L, Milnerwood A, Seibler P, Beccano-Kelly D, Tatarnikov I, Khinda J, et al. Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson’s disease VPS35 mutation p.D620N. Hum Mol Genet. 2015; doi: 10.1093/hmg/ddu582
16. Tian Y, Tang F-L, Sun X, Wen L, Mei L, Tang B-S, et al. VPS35-deficiency results in an impaired AMPA receptor trafficking and decreased dendritic spine maturation. Mol Brain. 2015; doi: 10.1186/s13041-015-0156-4
17. Tsika E, Glauser L, Moser R, Fiser A, Daniel G, Sheerin U-M, et al. Parkinson’s Disease-Linked Mutations in VPS35 Induce Dopaminergic Neurodegeneration. Hum Mol Genet. 2014; doi: 10.1093/hmg/ddu178
18. Zhang D, Isack NR, Glodowski DR, Liu J, Chen CC-H, Xu XZS, et al. RAB-6.2 and the retromer regulate glutamate receptor recycling through a retrograde pathway. J Cell Biol. 2012; doi: 10.1083/jcb.201104141
19. Wang C-L, Tang F-L, Peng Y, Shen C-Y, Mei L, Xiong W-C. VPS35 regulates developing mouse hippocampal neuronal morphogenesis by promoting retrograde trafficking of BACE1. Biol Open. 2012; doi: 10.1242/bio.20122451
20. Tang FL, Zhao L, Zhao Y, Sun D, Zhu XJ, Mei L, et al. Coupling of terminal differentiation deficit with neurodegenerative pathology in Vps35-deficient pyramidal neurons. Cell Death Differ. 2020; doi: 10.1038/s41418-019-0487-2
21. Temkin P, Morishita W, Goswami D, Arendt K, Chen L, Malenka R. The Retromer Supports AMPA Receptor Trafficking During LTP. Neuron. 2017; doi: 10.1016/j.neuron.2017.03.020
22. Vazquez-Sanchez S, Bobeldijk S, Dekker MP, Van Keimpema L, Van Weering JRT. VPS35 depletion does not impair presynaptic structure and function. Sci Rep. 2018; doi: 10.1038/s41598-018-20448-4
23. Linhart R, Wong SA, Cao J, Tran M, Huynh A, Ardrey C, et al. Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson’s disease mutant of Leucine-Rich Repeat Kinase 2 (LRRK2). Mol Neurodegener. 2014; doi: 10.1186/1750-1326-9-23
24. MacLeod DA, Rhinn H, Kuwahara T, Zolin A, Di Paolo G, McCabe BD, et al. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson’s disease risk. Neuron. 2013; doi: 10.1016/j.neuron.2012.11.033.RAB7L1
25. Inoshita T, Arano T, Hosaka Y, Meng H, Umezaki Y, Kosugi S, et al. Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila. Hum Mol Genet. 2017; doi: 10.1093/hmg/ddx179
26. Zhao Y, Perera G, Takahashi-Fujigasaki J, Mash DC, Vonsattel JPG, Uchino A, et al. Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers. Brain. 2018; doi: 10.1093/brain/awx344
27. Mir R, Tonelli F, Lis P, Macartney T, Polinski NK, Martinez TN, et al. The Parkinson’s disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human. Biochem J. 2018; doi: 10.1042/BCJ20180248
28. Vilariño-Güell C, Rajput A, Milnerwood AJ, Shah B, Szu-Tu C, Trinh J, et al. DNAJC13 mutations in Parkinson disease. Hum Mol Genet. 2013; doi: 10.1093/hmg/ddt570
29. Healy DG, Falchi M, O’Sullivan SS, Bonifati V, Durr A, Bressman S, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson’s disease: a case-control study. Lancet Neurol. 2008; doi: 10.1016/S1474-4422(08)70117-0
30. Beccano-Kelly DA, Kuhlmann N, Tatarnikov I, Volta M, Munsie LN, Chou P, et al. Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice. Front Cell Neurosci. 2014; doi: 10.3389/fncel.2014.00301
31. Beccano-Kelly DA, Volta M, Munsie LN, Paschall S a, Tatarnikov I, Co K, et al. LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory. Hum Mol Genet. 2014; doi: 10.3389/fncel.2014.00301
32. Cirnaru MD, Marte A, Belluzzi E, Russo I, Gabrielli M, Longo F, et al. LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex. Front Mol Neurosci. 2014; doi: 10.3389/fnmol.2014.00049
33. Piccoli G, Condliffe SB, Bauer M, Giesert F, Boldt K, De Astis S, et al. LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool. J Neurosci. 2011; doi: 10.1523/JNEUROSCI.3730-10.2011
34. Volta M, Cataldi S, Beccano-Kelly D, Munsie L, Tatarnikov I, Chou P, et al. Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release. Parkinsonism Relat Disord. 2015; doi: 10.1016/j.parkreldis.2015.07.025
35. Matikainen-Ankney BA, Kezunovic N, Mesias RE, Tian Y, Williams FM, Huntley GW, et al. Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson’s Disease-Linked LRRK2-G2019S Mutation. J Neurosci. 2016; doi: 10.1523/JNEUROSCI.3314-15.2016
36. Parisiadou L, Yu J, Sgobio C, Xie C, Liu G, Sun L, et al. LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity. Nat Neurosci. 2014. doi: 10.1038/nn.3636
37. Sweet ES, Saunier-Rebori B, Yue Z, Blitzer RD. The Parkinson’s disease-associated mutation LRRK2-G2019S impairs synaptic plasticity in mouse hippocampus. J Neurosci. 2015; doi: 10.1523/JNEUROSCI.0040-15.2015
38. Matikainen-Ankney BA, Kezunovic N, Menard C, Flanigan ME, Zhong Y, Russo SJ, et al. Parkinson’s disease-linked lrrk2-g2019s mutation alters synaptic plasticity and promotes resilience to chronic social stress in young adulthood. J Neurosci. 2018; doi: 10.1523/JNEUROSCI.1457-18.2018
39. Taylor M, Alessi DR. Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson’s disease. Curr Opin Cell Biol. 2020; doi: 10.1016/j.ceb.2020.01.001
40. Kuhlmann N, Milnerwood AJ. A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2. Front Mol Neurosci. 2020; doi: 10.3389/fnmol.2020.00153
41. Steger M, Tonelli F, Ito G, Davies P, Trost M, Vetter M, et al. Phosphoproteomics reveals that Parkinson’s disease kinase LRRK2 regulates a subset of Rab GTPases. Elife. 2016; doi: 10.7554/eLife.12813
42. Jeong GR, Jang EH, Bae JR, Jun S, Kang HC, Park CH, et al. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration. Mol Neurodegener. 2018; doi: 10.1186/s13024-018-0240-1
43. Di Maio R, Hoffman EK, Rocha EM, Keeney MT, Sanders LH, De Miranda BR, et al. LRRK2 activation in idiopathic Parkinson’s disease. Sci Transl Med. 2018; doi: 10.1126/scitranslmed.aar5429
44. McGough IJ, Steinberg F, Jia D, Barbuti PA, McMillan KJ, Heesom KJ, et al. Retromer Binding to FAM21 and the WASH Complex Is Perturbed by the Parkinson Disease-Linked VPS35(D620N) Mutation. Curr Biol. 2014; doi: 10.1016/j.cub.2014.06.024
45. Zavodszky E, Seaman MNJ, Moreau K, Jimenez-Sanchez M, Breusegem SY, Harbour ME, et al. Mutation in VPS35 associated with Parkinson’s disease impairs WASH complex association and inhibits autophagy. Nat Commun. 2014; doi: 10.1038/ncomms4828
46. Follett J, Norwood SJ, Hamilton N a, Mohan M, Kovtun O, Tay S, et al. The Vps35 D620N Mutation Linked to Parkinson’s Disease Disrupts the Cargo Sorting Function of Retromer. Traffic. 2013; doi: 10.1111/tra.12136
47. Cui Y, Yang Z, Flores-Rodriguez N, Follett J, Ariotti N, Wall AA, et al. Formation of retromer transport carriers is disrupted by the Parkinson disease-linked Vps35 D620N variant. Traffic. 2021; doi: 10.1111/tra.12779
48. Cataldi S, Follett J, Fox JD, Tatarnikov I, Kadgien C, Gustavsson EK, et al. Altered dopamine release and monoamine transporters in Vps35 p.D620N knock-in mice. npj Park Dis. 2018; doi: 10.1038/s41531-018-0063-3
49. Fell MJ, Mirescu C, Basu K, Cheewatrakoolpong B, DeMong DE, Ellis JM, et al. MLi-2, a potent, selective, and centrally active compound for exploring the therapeutic potential and safety of LRRK2 kinase inhibition. J Pharmacol Exp Ther. 2015; doi: 10.1124/jpet.115.227587
50. Kluss JH, Mazza MC, Li Y, Manzoni C, Lewis PA, Cookson MR, et al. Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo. Mol Neurodegener. 2021; doi: 10.1186/s13024-021-00441-8
51. Gomez TS, Billadeau DD. A FAM21-containing WASH complex regulates retromer-dependent sorting. Dev Cell. 2009; doi: 10.1016/j.devcel.2009.09.009
52. Derivery E, Sousa C, Gautier JJ, Lombard B, Loew D, Gautreau A. The Arp2/3 activator WASH controls the fission of endosomes through a large multiprotein complex. Dev Cell. 2009; doi: 10.1016/j.devcel.2009.09.010
53. Lee S, Chang J, Blackstone C. FAM21 directs SNX27-retromer cargoes to the plasma membrane by preventing transport to the Golgi apparatus. Nat Commun. 2016; doi: 10.1038/ncomms10939
54. Yap CC, Digilio L, McMahon L, Winckler B. The endosomal neuronal proteins Nsg1/NEEP21 and Nsg2/P19 are itinerant, not resident proteins of dendritic endosomes. Nat Sci Reports. 2017; doi: 10.1038/s41598-017-07667-x
55. Bodrikov V, Pauschert A, Kochlamazashvili G, Stuermer CAO. Reggie-1 and reggie-2 (flotillins) participate in Rab11a-dependent cargo trafficking, spine synapse formation and LTP-related AMPA receptor (GluA1) surface exposure in mouse hippocampal neurons. Exp Neurol. 2017; doi: 10.1016/j.expneurol.2016.12.007
56. Correia SS, Bassani S, Brown TC, Lisé M-F, Backos DS, El-Husseini A, et al. Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. Nat Neurosci. 2008; doi: 10.1038/nn2063
57. Esteves da Silva M, Adrian M, Schätzle P, Lipka J, Watanabe T, Cho S, et al. Positioning of AMPA Receptor-Containing Endosomes Regulates Synapse Architecture. Cell Rep. 2015; doi: 10.1016/j.celrep.2015.09.062
58. Jaafari N, Henley JM, Hanley JG. PICK1 Mediates Transient Synaptic Expression of GluA2-Lacking AMPA Receptors during Glycine-Induced AMPA Receptor Trafficking. J Neurosci. 2012; doi: 10.1523/JNEUROSCI.5068-11.2012
59. Seebohm G, Neumann S, Theiss C, Novkovic T, Hill E V., Tavaré JM, et al. Identification of a novel signaling pathway and its relevance for GluA1 recycling. PLoS One. 2012; doi: 10.1371/journal.pone.0033889
60. Bowen AB, Bourke AM, Hiester BG, Hanus C, Kennedy MJ. Golgi-Independent secretory trafficking through recycling endosomes in neuronal dendrites and spines. Elife. 2017; doi: 10.7554/eLife.27362
61. Benke T, Traynelis SF. AMPA-type glutamate receptor conductance changes and plasticity: still a lot of noise. Neurochem Res. 2019; doi: 10.1016/j.physbeh.2017.03.040
62. Diering GH, Huganir RL. The AMPA Receptor Code of Synaptic Plasticity. Neuron. 2018; doi: 10.1016/j.neuron.2018.10.018
63. Wang P, Liu H, Wang Y, Liu O, Zhang J, Gleason A, et al. RAB-10 Promotes EHBP-1 Bridging of Filamentous Actin and Tubular Recycling Endosomes. PLoS Genet. 2016; doi: 10.1371/journal.pgen.1006093
64. Bruno J, Brumfield A, Chaudhary N, Iaea D, McGraw TE. SEC16A is a RAB10 effector required for insulinstimulated GLUT4 trafficking in adipocytes. J Cell Biol. 2016; doi: 10.1083/jcb.201509052
65. Chen Y, Wang Y, Zhang J, Deng Y, Jiang L, Song E, et al. Rab10 and myosin-Va mediate insulin-stimulated GLUT4 storage vesicle translocation in adipocytes. J Cell Biol. 2012; doi: 10.1083/jcb.201111091
66. Pan X, Zaarur N, Singh M, Morin P, Kandror K V. Sortilin and retromer mediate retrograde transport of Glut4 in 3T3-L1 adipocytes. Mol Biol Cell. 2017; doi: 10.1091/mbc.E16-11-0777
67. Alshafie W, Francis V, Bednarz K, Pan YE, Stroh T, McPherson PS. Regulated resurfacing of a somatostatin receptor storage compartment fine-tunes pituitary secretion. J Cell Biol. 2020; doi: 10.1083/jcb.201904054
68. Glodowski DR, Chen CC-H, Schaefer H, Grant BD, Rongo C. RAB-10 regulates glutamate receptor recycling in a cholesterol-dependent endocytosis pathway. Mol Biol Cell. 2007; doi: 10.1091/mbc.E07
69. Pavlos NJ, Grønborg M, Riedel D, Chua JJE, Boyken J, Kloepper TH, et al. Quantitative analysis of synaptic vesicle Rabs uncovers distinct yet overlapping roles for Rab3a and Rab27b in Ca2+-triggered exocytosis. J Neurosci. 2010; doi: 10.4161/sgtp.2.2.15201
70. Tang F-L, Erion JR, Tian Y, Liu W, Yin D-M, Ye J, et al. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for -Synuclein Degradation and Prevention of Pathogenesis of Parkinson’s Disease. J Neurosci. 2015; doi: 10.1523/JNEUROSCI.0042-15.2015
71. Wen L, Tang F, Hong Y, Luo S, Wang C, He W, et al. VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology. J Cell Biol. 2011; doi: 10.1083/jcb.201105109
72. Seaman MNJ. Retromer and the cation-independent mannose 6-phosphate receptor—Time for a trial separation? Traffic. 2018; doi: 10.1111/tra.12542
73. Wang C, Niu M, Zhou Z, Zheng X, Zhang L, Tian Y, et al. VPS35 regulates cell surface recycling and signaling of dopamine receptor D1. Neurobiol Aging. 2016; doi: 10.1016/j.neurobiolaging.2016.05.016
74. Volta M, Beccano-Kelly DA, Paschall SA, Cataldi S, Macisaac SE, Kuhlmann N, et al. Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice. Elife. 2017; doi: 10.7554/eLife.28377
75. Yue M, Hinkle K, Davies P, Trushina E, Fiesel F, Christenson T, et al. Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock in mice. Neurobiol Dis. 2015; doi: 10.1016/j.nbd.2015.02.031
76. West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA, et al. Parkinson’s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A. 2005; doi: 10.1073/pnas.0507360102
77. Steger M, Diez F, Dhekne HS, Lis P, Nirujogi RS, Karayel O, et al. Systematic proteomic analysis of LRRK2-mediated rab GTPase phosphorylation establishes a connection to ciliogenesis. Elife. 2017; doi: 10.7554/eLife.31012
78. Schreij AM, Chaineau M, Ruan W, Lin S, Barker PA, Fon EA, et al. LRRK2 localizes to endosomes and interacts with clathrin-light chains to limit Rac1 activation. EMBO Rep. 2015; doi: 10.15252/embr.201438714
79. Picconi B, Piccoli G, Calabresi P. Synaptic Dysfunction in Parkinson’s Disease. In: Kreutz MR, Sala C, editors. Advances in Experimental Medicine and Biology vol. 970. Vienna: Springer; 2012. p. 553–72. doi: 10.1007/978-3-7091-0932-8
80. Volta M, Milnerwood AJ, Farrer MJ. Insights from late-onset familial parkinsonism on the pathogenesis of idiopathic Parkinson’s disease. Lancet Neurol. 2015; doi: 10.1016/S1474-4422(15)00186-6
81. Hinkle KM, Yue M, Behrouz B, Dächsel JC, Lincoln SJ, Bowles EE, et al. LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors. Mol Neurodegener. 2012; doi: 10.1186/1750-1326-7-25
82. Kriegstein a R, Dichter M a. Morphological classification of rat cortical neurons in cell culture. J Neurosci. 1983; doi: 10.1523/JNEUROSCI.03-08-01634.1983
83. Kaufman AM, Milnerwood AJ, Sepers MD, Coquinco A, She K, Wang L, et al. Opposing roles of synaptic and extrasynaptic NMDA receptor signaling in cocultured striatal and cortical neurons. J Neurosci. 2012; doi: 10.1523/JNEUROSCI.4129-11.2012
84. Brigidi GS, Sun Y, Beccano-Kelly D, Pitman K, Mobasser M, Borgland SL, et al. Palmitoylation of δ-catenin by DHHC5 mediates activity-induced synapse plasticity. Nat Neurosci. 2014; doi: 10.1038/nn.3657
85. Milnerwood AJ, Kaufman AM, Sepers MD, Gladding CM, Zhang L, Wang L, et al. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington’s disease mice. Neurobiol Dis. 2012; doi: 10.1016/j.nbd.2012.05.013
86. Traynelis SF, Silver RA, Cull-candy SC. Estimated Conductance of G lutamate Receptor Channels Activated during EPSCs at the Cerebellar Mossy Fiber-Granule Cell Synapse. Neuron. 1993; doi: 10.1016/0896-6273(93)90184-S
87. Hartveit E, Veruki ML. Studying properties of neurotransmitter receptors by non-stationary noise analysis of spontaneous postsynaptic currents and agonist-evoked responses in outside-out patches. Nat Protoc. 2007; doi: 10.1038/nprot.2007.47
88. Smith-Dijak AI, Nassrallah WB, Zhang LYJ, Geva M, Hayden MR, Raymond LA, et al. Impairment and Restoration of Homeostatic Plasticity in Cultured Cortical Neurons From a Mouse Model of Huntington Disease. Front Cell Neurosci. 2019; doi: 10.3389/fncel.2019.00209
89. Benke TA, Lüthi A, Palmer MJ, Wikström MA, Anderson WW, Isaac JTR, et al. Mathematical modelling of non-stationary fluctuation analysis for studying channel properties of synaptic AMPA receptors. J Physiol. 2001; doi: 10.1111/j.1469-7793.2001.00407.x